Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion by Chen, J et al.
Hypoxia potentiates Notch signaling in breast cancer leading
to decreased E-cadherin expression and increased cell migration
and invasion
J Chen
1, N Imanaka
1, J Chen
1 and JD Griffin*,1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
BACKGROUND: Epithelial-to-mesenchymal transition (EMT) is associated with decreased adhesion and acquisition of metastatic
potential of breast cancer cells. Epithelial-to-mesenchymal transition is mediated, in part, by two transcription repressors, Snail and
Slug, that are known to be targets of the Notch signaling pathway, and JAGGED1-induced Notch activation increases EMT. However,
the events that lead to increased Notch activity during EMT of breast cancer cells are unknown.
METHODS: The accumulation of hypoxia inducible factors (HIFs) under hypoxia was detected by western blot analysis, and their effects
on Notch signaling were measured by an in vitro Notch reporter assay. The expression of Notch target genes under hypoxia was
tested by real-time PCR. The knockdown of HIF-1a was mediated by retroviral delivery of shRNA. The expression of Slug and Snail
under hypoxia was measured by real-time PCR. Breast cancer cell migration and invasion under hypoxia were tested with cell
migration and invasion kits.
RESULTS: Hypoxia increased the expression of Notch target genes such as HES1 and HEY1 in breast cancer cells, as was expression of
Notch receptors and ligands. The mechanism is likely to involve the accumulation of HIF-1a and HIF-2a in these cells by hypoxia,
which synergised with the Notch co-activator MAML1 in potentiating Notch activity. Hypoxia inducible factor-1a was found to bind
to HES1 promoter under hypoxia. Knockdown of HIF-1a with shRNA inhibited both HES1 and HEY1 expression under hypoxia.
Hypoxia increased the expression of Slug and Snail, and decreased the expression of E-cadherin, hallmarks of EMT. Notch pathway
inhibition abrogated the hypoxia-mediated increase in Slug and Snail expression, as well as decreased breast cancer cell migration
and invasion.
CONCLUSION: Hypoxia-mediated Notch signaling may have an important role in the initiation of EMT and subsequent potential for
breast cancer metastasis.
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Notch signaling impinges on a wide variety of cellular processes,
including cell fate specification, cell proliferation, differentiation,
apoptosis and the maintenance of stem cells. Recent studies
suggested an important role for the Notch pathway in breast
cancer. Notch1 and Notch4 were identified as mouse mammary
tumour virus (MMTV) integration sites in murine mammary
tumours (Smith et al, 1995; Gallahan and Callahan, 1997; Dievart
et al, 1999). Transgenic mice harbouring constitutively active
Notch4 intracellular domain under the control of either MMTV
promoter (Smith et al, 1995) or whey acidic protein (WAP)
promoter (Gallahan et al, 1996) showed arrested mammary gland
development and eventually developed poorly differentiated adeno-
carcinomas. Mammary-specific over-expression of constitutively
active Notch1 or Notch3 intracellular domain led to the formation of
aggressive, metastatic breast tumours (Kiaris et al,2 0 0 4 ;H uet al,
2006). c-Myc was found to be a direct transcriptional target of
aberrant Notch1 signaling and was required for Notch1-induced
murine mammary tumourigenesis (Klinakis et al,2 0 0 6 ) .R e c e n t
studies also pointed to a role for Notch signaling in human breast
cancer. The expression of all four Notch receptors has been reported
in human breast cancer at varying frequencies (Callahan and Egan,
2004), and the expression of Notch ligands such as JAGGED1
correlated with a more aggressive disease course (Reedijk et al,
2005). JAGGED1-mediated Notch activation induced epithelial-to-
mesenchymal transition (EMT) (Leong et al, 2007). Furthermore,
low levels of the Notch antagonist Numb was found to correlate with
both high Notch signaling and sensitivity to a g-secretase inhibitor
(Pece et al, 2004). NOTCH1 has also been implicated as a
downstream effector of oncogenic Ras in human mammary
tumourigenesis (Weijzen et al, 2002). Recent studies also suggested
an important oncogenic collaboration between Wnt and Notch
pathways in breast tumourigenesis. Ectopic Wnt-1 expression
transformed human mammary epithelial cells through a mechanism
that requires an increase in Notch signaling (Ayyanan et al,2 0 0 6 ) .
Solid tumours often have low oxygen tension environments
because of insufficient and defective vascularisation. Tumour
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shypoxia is associated with enhanced invasiveness, angiogenesis
and distant metastasis. Hypoxia inducible factors (HIFs) are
heterodimeric proteins belonging to the basic helix-loop-helix
transcription factor families. Hypoxia inducible factor-1a is over-
expressed in many solid tumours, including breast cancer
(Semenza, 2003). Stabilisation and activation of HIF-1a transcrip-
tion complex also correlates with tumour metastasis and poor
prognosis in cancer patients (Harris, 2002; Semenza, 2002; Gupta
and Massague, 2006). Culture of lung cancer cells (Chen et al,
2007) or ovarian cancer cells (Sahlgren et al, 2008) under hypoxia
increased Notch pathway activation. Low oxygen content also
potentiated Notch signaling in melanocytes through stabilisation
of HIF-1a (Bedogni et al, 2008).
Epithelial-to-mesenchymal transition is one of the key mecha-
nisms that induce tumour invasion and metastasis (Thiery, 2002;
Thiery and Sleeman, 2006). Downregulation of E-cadherin is one of
the best markers of EMT in human breast cancer (Vincent-
Salomon and Thiery, 2003). Snail and Slug are two known
E-cadherin repressors that are thought to initiate EMT in breast
cancer (Martin et al, 2005). Upregulation of Snail correlates with
metastasis and poor prognosis, whereas silencing of Snail is critical
for reducing tumour growth and invasiveness (Perl et al, 1998;
Moody et al, 2005). Slug has also been shown to induce EMT
and metastasis through the repression of E-cadherin (Peinado
et al, 2007). The expression of Slug and Snail has been shown
to be regulated by Notch pathway (Leong et al, 2007; Sahlgren
et al, 2008).
In this study, we show that Notch signaling is potentiated in
human breast cancer cells by hypoxia. The mechanism is likely to
involve accumulation of both HIF-1a and HIF-2a under low
oxygen concentration, which then synergise with the Notch co-
activator MAML1 in potentiating Notch activity in an in vitro
Notch reporter assay. Chromatin immunoprecipitation (CHIP)
experiments showed that, with hypoxia, HIF-1a bound to human
HES1 promoter. shRNA-mediated knockdown of HIF-1a inhibited
hypoxia-induced HES1 and HEY1 expression, indicating the effect
of hypoxia on Notch signaling is via HIF transcription factors. The
expression of Slug and Snail was increased in breast cancer cells
with hypoxia, which in turn suppressed the expression of
E-cadherin. Finally, we found that Notch activation is required
for hypoxia-mediated breast cancer cell migration and invasion.
MATERIALS AND METHODS
Plasmids and antibodies
pcDNA3/HIF-1a (P402A/P564A) and pcDNA3/HIF-2a (P405A/
P531A) constructs were described earlier (Yan et al, 2007).
MAML1 full-length, dominant negative MAML1 (a.a. 13–74),
hemagglutinin (HA)-tagged murine ICN3 were described earlier
(Wu et al, 2000; Weng et al, 2003, 2004). pRL-TK (Promega)
encodes Renilla luciferase under the control of thymidine kinase
(TK) promoter and was used to normalise firefly luciferase
activities for transfection efficiency. HES1-luc contains the  194
to þ160 human HES1 promoter sequence that was cloned
upstream of the firefly luciferase gene in the pGL2 basic vector
(Promega, Madison, WI, USA). Hypoxia inducible factor-1a
shRNA constructs (TG320380) were from OriGene (Rockville,
MD, USA). mHes1 antibody was a gift from Dr Tetsuo Sudo.
Notch1 antibody (C-20-R), Notch3 antibody (M-134), Notch4
antibody (H-225), Jagged1 antibody (C-20), Maml1 antibody
N-20) and Slug antibody (D-19) were from Santa Cruz Biotechno-
logy Inc. (Santa Cruz, CA, USA), Notch2 antibody (C651.6DbHN)
was from Developmental Studies Hybridoma Bank at the
University of Iowa. Jagged2 antibody was from Cell Signaling
(Danvers, MA, USA). Hypoxia inducible factor-1a antibody was
from Novus (Littleton, CO, USA). Hypoxia inducible factor-2a
antibody was a gift from Dr Yoji Minamishima and Dr William
Kaelin Jr. E-cadherin antibody was from BD Biosciences (San Jose,
CA, USA). b-actin antibody was from Sigma-Aldrich (Saint Louis,
MO, USA).
Cell culture and transient transfection
Human osteosarcoma cell line U2OS, human breast cancer cell
lines MDA-468, MDA-231, MCF7, T47D, SK-BR-3 and ZR-75–1
were purchased from ATCC (Manassas, VA, USA) and were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) contain-
ing 10% fetal bovine serum. Transient transfections were carried
out using Lipofectamine 2000 transfection reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s instructions.
Real-time PCR
Total RNAs were isolated with the Trizol (Invitrogen) method, and
cDNAs were synthesised with SuperScript III first-strand synthesis
system (Invitrogen) from 1mg of total RNA. Real-time PCR was
performed with the cDNA samples and 2  SYBR PCR master
mixture (PE Applied Biosystems, Foster City, CA, USA) using an
ABI PRISM 7500 sequence detector (PE Applied Biosystems) and
the formation of PCR products were monitored using the SYBR
green method (PE Applied Biosystems). All samples were
amplified in duplicates. The relative changes in the amount of
transcripts in each sample were determined by normalising with
the b-actin mRNA levels. The sequences of the primers used in
real-time PCR are listed in Supplementary Table 1.
Notch reporter assay
U2OS cells were plated at 5 10
5 cells per well in the six-well plates
and were transfected the following day with cDNA constructs as
indicated in the figure legends using the Lipofectamine 2000
transfection reagent (Invitrogen). The total amounts of plasmid
DNA were kept constant by adding appropriate amounts of empty
vectors. Cell lysates were made at approximately 48h post-
transfection and the luciferase activities were measured with the
dual luciferase reporter assay systems (Promega). Relative
luciferase activities were determined by normalising HES1-luc
firefly luciferase activity with Renilla luciferase activity.
Western blot analysis
Human breast cancer cells were cultured under 21% O2 or 1% O2
conditions for the indicated time and cells were washed with ice-
cold PBS and were lysed in situ with a solution containing Tris
(20mM, pH 8.0), NaCl (150mM), 1% NP-40 (w/v), 10% glycerol
(w/v), NaF (100mM), 1mM phenylmethylsulphonyl fluoride
(PMSF), aprotinin (20mgml
–1), sodium orthovanadate (1mM;
Na3VO4) and leupeptin (40mgml
–1). After incubation on ice for
30min, cell lysates were centrifuged at 14000r.p.m. for 10min at
41C and the supernatants were used for gel electrophoresis. After
SDS–PAGE, the proteins were transferred to the PVDF
membranes. Membranes were blocked with 5% non-fat dry milk
in TBST (10mM Tris-HCl, pH 8.0, 150mM NaCl, 0.05% Tween20)
and were then incubated with primary antibodies overnight at 41C.
After washing five times for 10min each in TBST, membranes were
incubated with HRP-conjugated secondary antibodies for 1h,
washed again and the films were developed using a chemilumines-
cence method (ECL, PerkinElmer, Waltham, MA, USA).
Chromatin immunoprecipitation experiments
Breast cancer cells were cross-linked with 1% formaldehyde in
serum-free media at 371C for 10min. Cells were then washed twice
with ice-cold PBS and were resuspended with 300ml of lysis buffer
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inhibitor) and were incubated on ice for 10min. Cell lysates were
sonicated for three times at 10s each and were centrifuged for
10min at 14000r.p.m. at 41C. The supernatants were 1:10 diluted
with CHIP dilution buffer (1% Triton X-100, 2mM EDTA, 150mM
NaCl, 20mM Tris-HCl, pH 8.1, 1  protease inhibitor cocktail). In
all, 100ml Dynal magnetic protein-G beads (Invitrogen) were
washed twice with PBS plus BSA (5mgml
–1) and were incubated
with 5mg of either normal IgG or specific antibodies overnight at
41C. Beads were washed twice with PBS plus BSA (5mgml
–1) and
were incubated with 2ml diluted chromatins at 41C overnight.
Beads were then washed sequentially with 1ml buffer1 (0.1% SDS,
1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, 150mM
NaCl), buffer2 (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM
Tris-HCl, pH 8.1, 500mM NaCl), buffer3 (0.25M LiCl, 1% NP-40,
1% deoxycholate, 1mM EDTA, 10mM Tris-HCl, pH 8.1) and twice
with TE buffer. DNAs were eluted from the beads with 100mlo f
elution buffer (1% SDS, 0.1M NaHCO3) at RT for 30min. The
products were then incubated at 651C for 8h or overnight to
reverse the cross-linking. DNAs were extracted using the QIAGEN
PCR purification kit (Qiagen, Valencia, CA, USA). Real-time PCR
was performed with the primers flanking the RBP-Jk-binding sites of
human HES1 promoter. The sequences of the primers used in CHIP
and real-time PCR experiments are listed in Supplementary Table 1.
Cell invasion assay
This assay was performed using a cell invasion kit from Cell Biolabs,
Inc. (San Diego, CA, USA) Briefly, the invasion chambers were
warmed up at room temperature for 10min, and the basement
membrane layer was rehydrated with 300ml of warm serum-free
media for 1h at room temperature. After removing the rehydration
medium from the inserts, 300ml of 0.5–1.0 10
6 cellsml
–1 in
serum-free media ± GSI was added to the inside of each insert, and
500ml of media containing 10% fetal bovine serum ± GSI was added
to the lower well of the invasion plate. The plate was then incubated
at either 21% O2 or 1% O2 for 48h. The media was aspirated from
the inside of the insert and the non-invasive cells were removed. The
inserts were then transferred to clean wells containing 400mlo fc e l l
staining solution from the kit and were incubated for 10min at room
temperature. The stained inserts were washed several times with
water and were air-dried. Inserts were transferred to new wells with
agaggattttcaccacacaggaaaaccctacgtt
ttccaaaagcaacagacaattttctgtcatcacc
acttttccatctgtttaaaataagaaagaaaatt
ccttcccctttggcccaggttgcaggtcaacaaa
ggaggcattgttcatcatttcttcagaacatgac
agggcacagctcactctgcagtgtaa………………ca
aagggttaaaatccttttgattgacgttgtagcc
tccggtgccctgggctcaggcgcgcgccattggc
cgccagaccttgtgcctggcggccaatggggggg
cgcggtccacgagcggtgccgcgtgtctcctcct
cccattggctgaaagttacTGTGGGAAagaaagt
ttgggaagtTTCACACGagccgttcgcgtgcagt
cccagatatatatagaggccgccagggcctaggg
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Figure 1 Notch signaling is active in human breast cancer cells. (A) Expression of Notch receptors, ligands and Notch target gene HES1 in breast cancer
cells as detected by western blot analysis with specific antibodies. 468: MDA-468 cells; 231: MDA-231 cells. (B) Part of human HES1 5’ upstream sequence.
The RBP-Jk binding sites are capitalised. The primer sequences flanking the RBP-Jk binding sites are underlined. The control primer sequences at
approximately 3.7-kb upstream are also underlined. (C) Fold enrichment of the binding of NOTCH3 intracellular domain or MAML1 to the RBP-Jk binding
sites of human HES1 promoter in MCF7 cells with or without GSI treatment. Chromatin immunoprecipitation (CHIP) was performed with either normal
IgG, ICN3-specific antibody or MAML1 antibody followed by real-time PCR with primers flanking the RBP-Jk binding sites of human HES1 promoter.
*Po0.01; **Po0.05
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s200ml of extraction solution from the kit and were incubated for
10min with rotation. A volume of 100ml solution was used to
measure the OD 560nm in a spectrometer.
Cell migration assay
This assay was performed using a kit from Cell Biolabs, Inc. All
samples were tested in triplicates. Inserts were warmed up at room
temperature for 10min and their ‘wound field’ were aligned in the
same direction. A cell suspension containing 0.5–1.0 10
6 cellsml
–1
in media containing 10% fetal bovine serum was generated. In all,
500ml of cell suspension was added to each well. Cells were cultured
in the incubator until a monolayer formed. The inserts were then
carefully removed from the wells, and the wells were washed with
media to remove dead cells and debris. Finally, media ± GSI was
added to the wells and the plates were incubated at either 21% O2 or
1% O2 for 48h. The media was removed and 400ml of cell staining
solution from the kit was added to each well and were incubated for
15min at room temperature. The wells were washed three times with
deionised water and were air-dried at room temperature.
RESULTS
Notch signaling is active in human breast cancer cells
Western blot analysis showed that both NOTCH1 and NOTCH2
were expressed at different degrees in six human breast cancer cell
lines (Figure 1A). NOTCH3 expression was not detectable in MDA-
231 cells, but was detected in other five cell lines. There was no
detectable expression of NOTCH4 in these cancer cells by either
western blot analysis or RT–PCR (data not shown). As no gain-of-
function mutations of Notch receptors have been found in breast
cancer, ligand-mediated Notch activation still predominates in this
context. We examined the expression of Notch ligands in these
cancer cells and found that Notch ligand JAGGED1 was expressed
at different degrees in these cancer cells (Figure 1A). JAGGED2
expression was detected in MCF7, MDA-231, T47D and ZR-75-1
cells, but was barely detectable in other two cell lines (Figure 1A).
DELTA1 was expressed in MCF7, ZR-75-1 and T47D cells
(Figure 1A). There was no detectable expression of DELTA3 and
DELTA4 in these cancer cells (data not shown). The Notch target
gene HES1 was also expressed at high levels in these cells
(Figure 1A). Chromatin immunoprecipitation experiments showed
that NOTCH3 intracellular domain and Notch co-activator
MAML1 were present at the promoter of HES1 gene in MCF7
cells (Figures 1B and C). Similar results were also obtained from
MDA-468 cells (data not shown). g-secretase inhibitor (GSI)
treatment inhibited the binding of NOTCH3/MAML1 complex to
HES1 promoter (Figure 1C), indicating that Notch pathway is
active in these breast cancer cells and MAML1 might be a
co-activator of Notch signaling in breast cancer.
Accumulation of HIF-1a and HIF-2a in breast cancer cells
with hypoxia
Hypoxia inducible factors are heterodimeric proteins that belong
to the basic helix-loop-helix transcription factor families. Hypoxia
inducible factor-1a was expressed at a low level in MDA-231,
MDA-468
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Figure 2 Hypoxia inducible factor (HIF)-1a and HIF-2a accumulated in breast cancer cells with hypoxia and they potentiated Notch signaling.
(A) Western blot analysis of HIF-1a (the upper band marked by the arrow) and HIF-2a expression in breast cancer cells under 21% O2 or 1% O2 culture
conditions for 24h. H, hypoxia; N, normoxia. (B) Enhanced ICN3 signaling by HIF-1a or HIF-2a as determined by an in vitro Notch reporter assay, which was
inhibited by dominant negative MAML1. (C) Hypoxia inducible factor (HIF)-1a and HIF-2a synergise with MAML1 in potentiating ICN3-mediated Notch
signaling. (D) Enrichment of HIF-1a at HES1 promoter by hypoxia in MCF7 cells. Fold enrichment of the binding of HIF-1a to the RBP-Jk binding sites of
human HES1 promoter in MCF7 cells under 1% O2 culture condition. Normal IgG or HIF-1a-specific antibodies were used for CHIP experiments followed
by real-time PCR with primers flanking the RBP-Jk binding sites of HES1 promoter. H, hypoxia; N, normoxia; *Po0.01. (E) Increased binding of NOTCH3
intracellular domain to the RBP-Jk binding sites of HES1 promoter in MCF7 cells under hypoxia. H: hypoxia; N, normoxia; *Po0.05.
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sMDA-468, T47D, SK-BR-3 and ZR-75-1 cells under normal culture
conditions (Figure 2A). However, it dramatically accumulated in
these cells when they were cultured under hypoxia (Figure 2A),
except for SK-BR-3 cells, which have a higher basal level HIF-1a
expression. Hypoxia inducible factor-2a expression was only
detected at different degrees in MDA-468 and SK-BR-3 cells, but
not in other cell lines when they were cultured at regular culture
conditions. However, HIF-2a also dramatically accumulated in
these cells with hypoxia (Figure 2A).
HIF-1a and HIF-2a potentiated Notch signaling
Using an in vitro Notch reporter assay, we tested the effects of
HIF-1a and HIF-2a on Notch signaling. Both HIF-1a and HIF-2a
potentiated ICN1- and ICN3-induced Notch signaling, with HIF-2a
being more potent (Figure 2B and data not shown). Dominant
negative MAML1 (DNMAML1) can abrogate the effects of HIF
factors on Notch signaling, implicating MAML1 as a key co-
activator of this Notch activation complex (Figure 2B). Interest-
ingly, co-transfection of HIF-1a or HIF-2a with full-length MAML1
into cancer cells induced ICN3-mediated Notch signaling drama-
tically (Figure 2C), indicating a strong synergy between HIF factors
and MAML1 in the activation of Notch pathway.
Enrichment of HIF-1a and Notch intracellular domain at
HES1 promoter with hypoxia
To study the mechanisms whereby HIF-1a and HIF-2a augmented
Notch signaling in breast cancer cells, CHIP experiments with a
HIF-1a antibody in MCF7 cells were performed. Within human
HES1 promoter sequence, there are two RBP-Jk binding sites that
are approximately 16bp apart. Hypoxia inducible factor-1a was
enriched at these sites approximately three-folds after hypoxia
(Figure 2D). As there is no direct HIF-1a binding site within this
part of HES1 promoter, HIF-1a was likely enriched through its
binding to the intracellular domain of Notch receptors (Gustafsson
et al, 2005). The binding of NOTCH3 intracellular domain to HES1
promoter was also increased in MCF7 cells when they were
cultured under 1% O2 condition (Figure 2E).
Increased expression of Notch target genes in breast
cancer cells with hypoxia
We then examined the expression of Notch target genes in these
breast cancer cells when they were cultured at either normoxic or
hypoxic conditions. The expression of Notch target genes such as
HES1 and HEY1 were increased in MCF7 cells and MDA-468 cells
when they were cultured at 1% O2 condition (Figure 3), indicating
that hypoxia, presumably through induction of HIF factor
expression, regulates Notch signaling in breast cancer cells.
Culture of other breast cancer cells under hypoxia also increased
the expression of HES1 and HEY1 to different degrees (Figure 3),
except for SK-BR-3 cells, which did not have an elevated HES1
expression under hypoxic conditions.
HES1 was highly expressed in these cancer cells under normal
culture conditions. However, the increase of HES1 expression
under hypoxia was not dramatic. HEY1 expression was at a very
low level in these cancer cells under normoxia, and was greatly
induced in these cells with hypoxia, indicating HEY1 gene is an
excellent potential marker of Notch pathway activation in human
breast cancer cell lines.
To study whether the effect of hypoxia on HES1 and HEY1
expression is mediated by HIF transcription factors, we knocked
down HIF-1a expression with shRNA and found that both
HES1 and HEY1 expression were inhibited (Figure 4), indicating
that their increased expression under hypoxia is HIF-1a
dependant.
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when they were cultured at low oxygen concentration. Hypoxia
increased NOTCH3 expression in MDA-468, MCF7 and T47D cells
and this increase was abrogated by GSI treatment (Figure 5A). In
addition to NOTCH3, the expression of Notch ligands JAGGED1
and JAGGED2 was also increased in these cells by hypoxia
(Figure 5B). DELTA1 expression was also elevated in MCF7 cells
and MDA-468 cells by hypoxia (Figure 5C). Finally, elevated HES1-
luc reporter gene activity was detected in the transfected MCF7
cells when they were cultured at 1% O2 condition (Figure 5D).
Altered expression of Slug, Snail and E-cadherin in breast
cancer cells with hypoxia
Zinc-finger proteins Slug and Snail are two known E-cadherin
repressors that initiate EMT in breast cancer. The expression of
Slug and Snail has been shown to be regulated by Notch pathway.
Snail expression was increased significantly in MDA-468 and T47D
breast cancer cells with hypoxia, and this increase was abrogated
by GSI treatment (Figure 6A). Inhibition of Notch signaling by
DNMAML1 in MDA-468 cells and T47D cells also abrogated
hypoxia-mediated Snail expression (Figure 6A). Snail expression
was also slightly increased in MCF7 cells with hypoxia. Slug is only
expressed in MDA-231 cells under regular culture conditions. With
hypoxia, Slug expression was increased in MDA-231 cells
(Figure 6B), and this increased expression was also abrogated by
GSI treatment (Figure 6B).
E-cadherin is a cell–cell adhesion molecule that participates
in calcium-dependant interactions to form epithelial adherens
junctions. Downregulation of E-cadherin is one of the best markers
of EMT in human breast cancer. E-cadherin was expressed at
different degrees in MDA-468, MCF7 and T47D cells (Figure 6C),
but was not expressed in MDA-231 and SK-BR-3 cells (data not
shown). Under hypoxia, the mRNA levels of E-cadherin were
reduced in MDA-468, MCF7 and T47D cells (Figure 6C). The GSI
treatment abrogated the downregulation of E-cadherin by hypoxia
in these cell lines (Figure 6C). E-cadherin protein levels were also
decreased in MCF7 cells when they were cultured under hypoxic
conditions (Figure 6D). Inhibition of Notch signaling by
DNMAML1 abrogated the downregulation of E-cadherin observed
during hypoxia in MCF7 cells (Figure 6D).
Notch signaling is required for hypoxia-mediated breast
cancer cell migration and invasion
Increased cell migration and invasion are important consequences
of hypoxia-induced EMT. To study the effects of hypoxia on breast
cancer cell motility and invasiveness, and whether Notch signaling
is required for these effects, breast cancer cells from 21 or 1% O2
culture conditions with or without the GSI treatment were applied
to a scratch wound-healing assay. Culture of MDA-468 cells under
hypoxia increased the closure of the scratch wound compared with
the control (Figure 7A). The GSI treatment inhibited the migration
of MDA-468 cells across the scratch wound (Figure 7A). To study
the invasive properties of these breast cancer cells under normoxia
or hypoxia, a basement membrane invasion assay was performed.
Culture of MDA-468 cells at 1% O2 concentration increased the
migration of these cells across a membrane toward a source of
serum attraction (Figures 7B and C). The GSI treatment of MDA-
468 cells or transfection of DNMAML1 inhibited the migration of
these cells across the membrane (Figures 7B and C), indicating that
Notch pathway is required for hypoxia-mediated breast cancer cell
migration and invasion.
DISCUSSION
Our study showed that both HIF-1a and HIF-2a accumulated in
breast cancer cells with hypoxia and they potentiated Notch
signaling. Notch target gene expression was induced in these cells
when they were cultured at low oxygen conditions. shRNA-
mediated knockdown of HIF-1a abrogated hypoxia-induced HES1
and HEY1 expression, indicating the effect of hypoxia on Notch
activation is via HIF factors. Interestingly, HIF-1a and HIF-2a
synergised with MAML1 in the activation of Notch pathway in the
in vitro Notch reporter assay and dominant negative MAML1 can
block HIF-induced Notch signaling, indicating MAML1 as a key
co-activator among the Notch activation complex. MAML1 has
been detected earlier as part of a Notch/HIF/MAML1 immuno-
complex (Sahlgren et al, 2008). We did not detect a direct
interaction between HIF factors and full length MAML1 or RBP-Jk
(J Chen and J Griffin, unpublished data). Therefore, MAML1 and
HIF factors may form a complex with Notch intracellular domain
and function as scaffold proteins to recruit CBP/p300 and other
Notch co-activators to the whole complex.
SK-BR-3 cells have a higher basal level expression of both
HIF-1a and HIF-2a compared with other breast cancer cells. Under
hypoxia, the expression of HIF-1a in these cells was not increased
while the expression of HIF-2a was slightly elevated. This might
be the reason why there was only two-fold increase of HEY1
expression and no elevated HES1 expression in these cells
with hypoxia.
To date, cell autonomous gain-of-function mutations in Notch
receptors have not been reported in human breast cancers and
other solid tumours, suggesting that ligand-mediated Notch
activation predominates in these contexts. We detected the
expression of Notch ligands JAGGED1, JAGGED2 and DELTA1
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cells under hypoxia with the knockdown of HIF-1a by shRNA. *Po0.05,
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stimulation of Notch pathway in these cells. Elevated NOTCH3
expression was detected in MCF7, MDA-468 and T47D cells after
hypoxia, and the expression of JAGGED1, JAGGED2 and DELTA1
ligands was also increased in these cells after they were cultured
at 1% O2 condition. This indicated that increased ligand levels
and stabilisation of Notch receptors are likely to act together to
increase Notch signaling under hypoxia. Furthermore, our studies
suggested that hypoxia not only potentiate the pre-existing
Notch signaling in breast cancer cells, it also induce Notch
signaling by increasing the expression of both Notch receptors
and ligands.
Our study found that the expression of Notch target genes HES1
and HEY1 was increased in most breast cancer cells with hypoxia.
However, the increased HEY1 expression by hypoxia was more
dramatic compared with HES1 expression, indicating HEY1 might
be a better marker of Notch activation in breast cancer cells.
Previous studies also showed that HEY genes are the most sensitive
Notch target genes for Notch pathway inhibition in breast cancer
(Leong et al, 2007). Positive expression correlations between
JAGGED1 and HEY genes have also been identified in primary
human breast cancer (Leong et al, 2007).
Epithelial-to-mesenchymal transition is characterised by loss of
cell adhesion, repression of E-cadherin expression and increased
cell mobility. Induction of EMT in immortalised human mammary
epithelial cells results in the expression of stem cell markers (Mani
et al, 2008). Several oncogenic pathways such as TGF-b, receptor
tyrosine kinases (RTKs), integrin, endothelin A receptor, Wnt/
beta-catenin, hypoxia, matrix metalloproteinase (MMPs) and
Notch induce EMT (Polyak and Weinberg, 2009). Downregulation
of E-cadherin is one of the best markers of EMT in breast cancers.
Zinc-finger proteins Snail and Slug are two transcriptional
repressors of E-cadherin and their expression induces EMT
and promotes malignant cell invasion and dissemination. Other
E-cadherin transcriptional repressors include SIP1, TWIST1,
FOXC2, FOXC1 and ZEB1 (Polyak and Weinberg, 2009). Some
non-coding microRNAs have also been implicated as regulators of
EMT and tumour metastasis (Ma et al, 2007; Gregory et al, 2008;
Park et al, 2008; Tavazoie et al, 2008).
Previous studies have suggested that Notch signaling induces a
particular type of EMT during normal heart development and that
Notch increases Snail expression in endothelial cells to promote
mesenchymal transformation (Noseda et al, 2004; Timmerman
et al, 2004). Recent studies showed that JAGGED1-induced Notch
signaling induces EMT through Slug-mediated repression of
E-cadherin (Leong et al, 2007). Over-expression of NOTCH1
intracellular domain, but not HES1 or HEY1, inhibits E-cadherin
expression and induces EMT in ovarian cancer cells, probably
through the induction of Snail expression (Sahlgren et al, 2008).
Our studies indicate that hypoxia may be an initiative event
resulting in enhanced Notch signaling, increasing the expression of
Slug and Snail in breast cancer cells, which in turn inhibited
E-cadherin expression. Inhibition of Notch signaling by dominant
negative MAML1 abrogated the downregulation of E-cadherin
observed during hypoxia. Culture of breast cancer cells under
hypoxia increased their migration and invasion, which is abolished
by Notch pathway inhibition with either GSI treatment or
DNMAML1. These studies suggested that Notch signaling is not
only required for the proliferation of breast cancer cells under
regular culture conditions, it is also required, under hypoxia, to
further activate Notch signaling, to initiate EMT, and thereby
increasing the likelihood of increased breast cancer cell migration,
invasion and metastasis. Over the short term, pharmacological
inhibitors of ligand-induced Notch signaling might be able to
block EMT and tumour metastasis in the treatment of human
breast cancer.
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Figure 5 Increased Notch receptor and Notch ligand expression in breast cancer cells by hypoxia. (A) Western blot analysis of the expression of
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